Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70010-127

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70010-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupro-sr-100mg-30s (Bupro Sr 100mg 30s)

Bupro-sr-100mg-30s (Bupro Sr 100mg 30s)
This text contains information about a drug with the NDC 70010-125-03 number. It mentions that each extended-release tablet contains 100 mg of bupropion hydrochloride, USP. The text also provides dosage information, storage conditions, and a warning not to use the medication in combination with ZYBAN® or any other medicines containing bupropion hydrochloride. It advises pharmacists to dispense the medication guide separately to each patient. The medication should be stored at room temperature, protected from light and moisture.*
FDA Label Image

Bupro-sr-150mg-30s (Bupro Sr 150mg 30s)

Bupro-sr-150mg-30s (Bupro Sr 150mg 30s)
This is a description of an extended-release tablet containing 150 mg of bupropion hydrochloride, USP, with dosing information provided for twice-a-day administration. Storage instructions include keeping the tablets between 15°C and 30°C. Pharmacists are advised to dispense the medication guide separately to each patient. A warning against using this medication in combination with ZYBAN® or other medicines is given. The manufacturer is identified as GlaxoSmithKline.*
FDA Label Image

Bupro-sr-200mg-30s (Bupro Sr 200mg 30s)

Bupro-sr-200mg-30s (Bupro Sr 200mg 30s)
This text provides information on a medication containing bupropion hydrochloride in extended-release tablet form. It includes details about dosage instructions, storage conditions, and manufacturer information. The medication is to be dispensed with a Medication Guide and stored at room temperature. The text also mentions a warning about not using the medication in combination with other products containing bupropion hydrochloride.*
FDA Label Image

Bupro-sr-structure (Bupro Sr Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.